Reciprocal regulation of Abl and receptor tyrosine kinases

Divyamani Srinivasan1, David M Kaetzel, Rina Plattner

  • 1Department of Molecular and Biomedical Pharmacology, University of Kentucky School of Medicine, 800 Rose Street, Lexington, KY 40346, USA.

Cellular Signalling
|March 12, 2009
PubMed

Insights

Abl kinases are activated by PDGF and Her-2, promoting cancer cell growth. They also form a feedback loop, with Abl kinases downregulating PDGF receptor signaling in glioblastoma and breast cancer.

Area of Science:

  • Oncology
  • Cell Signaling
  • Molecular Biology

Background:

  • Abl kinases (c-Abl, Arg) are activated by platelet-derived growth factor (PDGF) and promote fibroblast proliferation and migration.
  • Abl kinases bind directly to PDGF receptor beta (PDGFR-beta) via their SH2 domains.
  • Abl kinases are highly active in breast cancer, with Her-2 receptor tyrosine kinase contributing to their activation.

Purpose of the Study:

  • To investigate the role of the PDGFR-Abl signaling pathway in glioblastoma development.
  • To elucidate the interaction between Abl kinases and Her-2.
  • To understand the functional consequences of PDGFR-beta phosphorylation by Abl kinases.

Main Methods:

  • Site-directed mutagenesis to study phosphorylation sites.
  • In vitro kinase assays.
  • Analysis of signaling pathways in glioblastoma and breast cancer cells.

Main Results:

  • Abl kinases are activated by autocrine PDGF loops in glioblastoma cells.
  • Abl kinase SH2 domains bind Her-2, and Her-2 directly phosphorylates c-Abl.
  • PDGFR-beta phosphorylates Abl kinases on activation sites (Y245, Y412) and Arg on unique sites.
  • Abl kinases phosphorylate PDGFR-beta on Y686, Y934, and Y970, activating PDGFR-beta activity but downregulating chemotaxis.

Conclusions:

  • The PDGFR-Abl signaling pathway is crucial for glioblastoma development and progression.
  • Abl kinases interact with both PDGFR-beta and Her-2.
  • Abl kinases modulate PDGFR-beta activity through a negative feedback loop, impacting cell migration and chemotaxis.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...